Clinical Trials Directory

Trials / Completed

CompletedNCT04219098

Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Anne Arundel Health System Research Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.

Detailed description

This study is designed to be prospective randomized (1:1) controlled independent trial. Subjects are male and female, aged 18 and above, who are suitable candidates for either a unilateral (i.e. single) total hip replacement. Subjects that are scheduled with a single, extensively trained Physician Assistant assisting in their surgery will be exclusively included. This is single site study with projected enrollment of 150 subjects

Conditions

Interventions

TypeNameDescription
PROCEDUREButterfly IQ10ml of solution with .5cc (or one drop) sterile methylene blue will be injected intra-articularly under ultrasound guidance after a sterile prep. The remaining 20ml will be injected into the periarticular tissues after prosthesis implantation before closure.
OTHERStandard of CareThe entire volume will be injected into the periarticular tissues after prosthesis implantation before closure.

Timeline

Start date
2020-02-01
Primary completion
2021-07-30
Completion
2021-08-30
First posted
2020-01-06
Last updated
2024-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04219098. Inclusion in this directory is not an endorsement.